COO Q3 2024 Earnings — The Cooper Companies, Inc. Revenue & Financial Results | Market Cap Arena

COOThe Cooper Companies, Inc.

$15B

Q3 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$1.0B+7.8% YoY

Gross Profit

$663M66.1% margin

Operating Income

$193M19.2% margin

Net Income

$105M10.4% margin

EPS (Diluted)

$0.52

QoQ Revenue Growth

+6.4%

Cash Flow

Operating Cash Flow

$208M

Free Cash Flow

$119M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$12.1B

Total Liabilities

$4.2B

Stockholders' Equity

$7.9B

Cash & Equivalents

$110M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.0B	$930M	+7.8%
Gross Profit	$663M	$610M	+8.7%
Operating Income	$193M	$152M	+27.0%
Net Income	$105M	$85M	+22.7%

Revenue Segments

Coopervision Segment

$676M67%

Coopersurgical Segment

$327M33%

Geographic Segments

UNITED STATES

$511M51%

Europe

$297M30%

Rest Of World, Excluding United States And Europe

$195M19%